Thank you, Mr. Minister and officials, for being here.
I certainly can't speak for all Canadians. I wouldn't suggest that I could. I can speak for many of the residents in the constituency in which I live, which is Surrey North, and I can speak based on information that I get as the health critic for the NDP on correspondence that comes from Canadians who are concerned about our health care system.
Many people voted for the Conservative Party because they put faith in the promise that you made about wait times. I am hearing from people that they are concerned that they have misplaced their faith. I'm not going to take up time. Ms. Dhalla has covered wait times very well, but I needed to reinforce that I am hearing the same kinds of things that Ms. Dhalla has gone over.
I'd like to ask you three questions. I will do them quickly so you will have an opportunity to respond.
I realize, since you and I have both done this before, that hepatitis C has to go before the courts, but I don't know that it is not possible to put out an interim amount—because people are indeed dying, and they have, and we can name some who have died since the announcement was made—in order to at least help people get to that stage where they will have some money to be able to eat properly and nourish themselves, because they are suffering from this disease.
I'd like to ask about the elimination of the Inuit tobacco control strategy, which has some irony for me, because you announced a pilot project for prenatal aboriginal women, which is around wait times, and yet they will go back to a community where their tobacco cessation program has been eliminated. They will go back into homes and into communities where people are smoking at considerably higher rates than we might see outside the reserves or outside their homes. On eliminating the tobacco strategy, it's about 10%, or more than 10% actually, of the annual tobacco control budget. How is that community being serviced now? Was the previous strategy not working? Usually if a strategy isn't working, you alter it as you go along. You don't wait until the end of a project and then say now it's done. Is somebody creating a new strategy for that?
The second question I'd like to ask, if I could, is around the patent drugs and the additional dollars being asked for in supplementary estimates, which are normally unforeseen expenditures. Why is it unforeseen that so many people are going to come and want to talk at public hearings about patent drugs? Although I'm very optimistic that if you're having public hearings on patent drugs, it will indeed lead to the lower cost of drugs for people, I'm sure the intention of your public hearings is to lower the drug costs for people who are suffering from that.
My last comment would be about the Assisted Human Reproductive Agency. We have an agency on which we are spending money that does not have a board of directors. The regulations we have not yet seen. I don't know who has developed the infrastructure, who signs this off. If all this can be done without a board, why are we spinning it off at all? It seems that we have this agency on which we are spending a lot of money that doesn't really exist. I'm a little puzzled, and I would like to know how that money is actually being spent and when there will actually be an agency up and running, given the money that's going into it.